menu

The Evolution of the Metastatic Prostate Cancer and Non-metastatic Castration-Resistant Prostate Cancer Landscape

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

The Evolution of the Metastatic Prostate Cancer and Non-metastatic Castration-Resistant Prostate Cancer Landscape

Program Information
Recommended

Program Information

The Evolution of the Metastatic Prostate Cancer and Non-metastatic Castration-Resistant Prostate Cancer Landscape
RestartResume

In 2020 alone, it’s estimated more than 191,000 new cases of prostate cancer were diagnosed in the U.S. Learn how the clinical landscape is evolving.

  • Sponsored by

  • Overview

    Prostate cancer is one of the most common cancers in men in the United States. In a program sponsored by Astellas and Pfizer, Drs. Maha Hussain and Christopher Evans discuss the history and how care is evolving for men with metastatic prostate cancer and non-metastatic castration-resistant prostate cancer.

    This program is intended for United States health care professionals only. Drs. Hussain and Evans have recevied compensation from Astellas and Pfizer for their time.

    074-0391-PM 

Programs 8/3/21